Karyopharm Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
CEORichard A. Paulson
CEORichard A. Paulson
Employees279
Employees279
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees279
Employees279
KPTI Key Statistics
Market cap36.29M
Market cap36.29M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume73.10K
Average volume73.10K
High today$4.65
High today$4.65
Low today$4.15
Low today$4.15
Open price$4.48
Open price$4.48
Volume112.05K
Volume112.05K
52 Week high$17.40
52 Week high$17.40
52 Week low$3.51
52 Week low$3.51
KPTI News
Simply Wall St 7d
Investors Don't See Light At End Of Karyopharm Therapeutics Inc.'s Tunnel And Push Stock Down 27%Unfortunately for some shareholders, the Karyopharm Therapeutics Inc. ( ) share price has dived 27% in the last thirty days, prolonging recent pain. The recent...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own KPTI. This list is generated using Robinhood data, and it’s not a recommendation.